Eating Disorders: National Institute of Mental Health's Perspective

American Psychologist

Volumn 62, Issue 3, 2007, Pages 159-166

  Chavez, Mark ^a   Insel, Thomas R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

eating disorders; NIMH; pathophysiology; treatment

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DRUG THERAPY; EATING DISORDER; HUMAN; MENTAL HEALTH SERVICE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; UNITED STATES;

COMBINED MODALITY THERAPY; DRUG THERAPY; EATING DISORDERS; HUMANS; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTHERAPY; UNITED STATES;

EID: 34548426138     PISSN: 0003066X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0003-066X.62.3.159     Document Type: Article

References (57)

1. Agras W.S., Brandt H., Bulik C., Dolan-Sewell R., Fairburn C.G., Halmi K.A., et al. Report of the National Institutes of Health Workshop on Overcoming Barriers to Treatment Research in Anorexia Nervosa. International Journal of Eating Disorders 35 (2004) 509-521
2. Agras W.S., Crow S.J., Halmi K.A., Mitchell J.E., Wilson G.T., and Kraemer H.C. Outcome predictors for the cognitive behavior treatment of bulimia nervosa: Data from a multisite study. American Journal of Psychiatry 157 (2000) 1302-1308
3. Agras W.S., Rossiter E.M., Arnow B., Schneider J.A., Telch C.F., Raeburn S.D., et al. Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: A controlled comparison. American Journal of Psychiatry 149 (1992) 82-87
4. Altshuler D., Brooks L.D., Chakravarti A., Collons F.S., Daly M.J., and Donnelly P. A haplotype map of the human genome. Nature 437 (2005, October 27) 1241-1242
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), Author, Washington, DC
6. Appolinario J.C., Bacaltchuk J., Sichieri R., Claudino A.M., Godoy-Matos A., Morgan C., et al. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Archives of General Psychiatry 60 (2003) 1109-1116
7. Arnold L.M., McElroy S.L., Hudson J.I., Wegele J.A., Bennet A.J., and Kreck Jr. P.E. A placebo-controlled randomized trial of fluoxetine in the treatment of binge-eating disorder. Journal of Clinical Psychiatry 63 (2002) 1028-1033
8. Attia E., Haiman C., Walsh B.T., and Flater S.R. Does fluoxetine augment the inpatient treatment of anorexia nervosa?. American Journal of Psychiatry 155 (1998) 548-551
9. Attia E., and Schroder L. Pharmacologic treatment of anorexia nervosa: Where do we go from here?. International Journal of Eating Disorders 37 (2005) 61-63
10. Bailer U., de Zwaan M., Leisch F., Strnad A., Lennkh-Wolfsberg C., El-Giamal N., et al. Guided self-help versus cognitive-behavioral group therapy in the treatment of bulimia nervosa. International Journal of Eating Disorders 35 (2004) 522-537
11. Barbarich N.C., McConaha C.W., Halmi K.A., Gendal K., Sunday S.R., Gaskill J., et al. Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa. International Journal of Eating Disorders 35 (2004) 10-15
12. Berkman N.D., Bulik C.M., Brownley K.A., Lohr K.N., Sedway J.A., Rooks A., and Gartlehner G. Management of eating disorders (Evidence Report/Technology Assessment No. 135, AHRQ Publication No. 06-E010) (2006, April), Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, Rockville, MD
13. Berthoud H.R. Multiple neural systems controlling food intake and body weight. Neuroscience and Biobehavioral Reviews 26 (2002) 393-428
14. Beumont P.J., Russel J.D., Touyz S.W., Buckley C., Lowinger K., Talbot P., and Johnson G.F. Intensive nutritional counseling in bulimia nervosa: A role for supplementation with fluoxetine. Australian and New Zealand Journal of Psychiatry 31 (1997) 514-524
15. Birmingham C.L., Su J., Hlynsky J.A., Goldner E.M., and Gao M. The mortality rate from anorexia disorder. International Journal of Eating Disorders 38 (2005) 143-146
16. Bulik C.M., Sullivan P.F., Carter F.A., McIntosh V.V., and Joyce P.R. The role of exposure with response prevention in cognitive-behavioural therapy for bulimia nervosa. Psychological Medicine 28 (1998) 611-623
17. Bullock T.H., Bennett M.V., Johnston D., Josephson R., Marder E., and Fields R.D. The neuron doctrine, redux. Science 310 (2005, November 4) 791-793
18. Dare C., Eisler I., Russell G., Treasure J., and Dodge L. Psychological therapies for adults with anorexia nervosa: Randomized controlled trial of outpatient treatments. British Journal of Psychiatry 178 (2001) 216-221
19. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
20. Eisler I., Dare C., Hodes M., Russell G., Dodge E., and Le Grange D. Family therapy for adolescent anorexia nervosa: The result of a controlled comparison of two family interventions. Journal of Child Psychology and Psychiatry 41 (2000) 727-736
21. Fairburn C., and Walsh B.T. Atypical eating disorders (eating disorder not otherwise specified). In: Fairburn C.G., and Brownell K.D. (Eds). Eating disorders and obesity: A comprehensive handbook. 2nd ed. (2002), Guilford Press, New York 171-177
22. Fitzgerald K.D., Welsh R.C., Gehring W.J., Abelson J.L., Himle J.A., et al. Error-related hyperactivity of the anterior cingulated cortex in obsessive-compulsive disorder. Biological Psychiatry 57 (2005) 287-294
23. Flament M.F., Godart N.T., Fermanian J., and Jeammet P. Predictive factors of social disability in patients with eating disorders. Eating and Weight Disorders 6 (2001) 99-106
24. Goldstein D.J., Wilson M.G., Thompson V.L., Potvin J.H., and Rampey Jr. A.H. Long-term fluoxetine treatment of bulimia nervosa: Fluoxetine Bulimia Nervosa Research Group. British Journal of Psychiatry 166 (1995) 660-666
25. Grilo C.M., Masheb R.M., and Wilson G.T. Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: A randomized double-blind placebo-controlled comparison. Biological Psychiatry 57 (2005) 301-309
26. Halmi K.A., Eckert E.D., LaDu T.J., and Cohen J. Anorexia nervosa: Treatment efficacy of cyproheptadine and amitriptyline. Archives of General Psychiatry 49 (1986) 177-181
27. Halmi K.A., Eckert E., Marchi P., Sampugnaro V., Apple R., and Cohen J. Comorbidity of psychiatric diagnoses in anorexia nervosa. Archives of General Psychiatry 48 (1991) 712-718
28. Hilbert A., and Tuschen-Caffier B. Body image interventions in cognitive-behavioral therapy of binge-eating disorder: A component analysis. Behavioral Research and Therapy 42 (2004) 1325-1339
29. Horvath T.L., Diano S., and Tschop M. Brain circuits regulating energy homeostasis. Neuroscientist 10 (2004) 235-246
30. Hudson J.I., McElroy S.L., Raymond N.C., Crow S., Keck Jr. P.E., Carter W.P., et al. Fluvoxamine in the treatment of binge-eating disorder: A multi-center placebo-controlled, double-blind trial. American Journal of Psychiatry 155 (1998) 1756-1762
31. Insel T.R., and Quirion R. Psychiatry as a clinical neuroscience discipline. Journal of the American Medical Association 294 (2005) 2221-2224
32. Kaye W.H., Bailer U.F., Frank G.K., and Henry S.E. Brain imaging of serotonin after recovery from anorexia nervosa and bulimia nervosa. Physiology and Behavior 86 (2005) 15-17
33. Kaye W.H., Bulik C., Thornton L., Barbarich N., and Masters K. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. American Journal of Psychiatry 161 (2004) 2215-2221
34. Kaye W.H., Nagata T., Weltzin T.E., Hsu L.K., Sokol M.S., McConaha C., et al. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biological Psychiatry 49 (2001) 644-652
35. Keel P.K., Dorer D.J., Eddy K.T., Franko D., Charatan D.L., and Herzog D.B. Predictors of mortality in eating disorders. Archives of General Psychiatry 60 (2003) 179-183
36. McElroy S.L., Arnold L.M., Shapira N.A., Keck Jr. P.E., Rosenthal N.R., Karim M.R., et al. Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial. American Journal of Psychiatry 160 (2003) 255-261
37. McElroy S.L., Casuto S.L., Nelson E.B., Lake K.A., Soutullo C.A., Keck Jr. P.E., and Hudson J.I. Placebo-controlled trial of sertraline in the treatment of binge eating disorder. American Journal of Psychiatry 157 (2000) 1004-1006
38. McElroy S.L., Hudson J.I., Malhorta S., Wegle J.A., Nelson E.B., and Keck Jr. P.E. Citalopram in the treatment of binge-eating disorder: A placebo-controlled trial. Journal of Clinical Psychiatry 64 (2003) 807-813
39. McIntosh V.V., Jordan J., Carter F.A., Luty S.E., McKenzie J.M., Bulik C.M., et al. Three psychotherapies for anorexia nervosa: A randomized, controlled trial. American Journal of Psychiatry 162 (2005) 741-747
40. McKenzie J.M., and Joyce P.R. Hospitalization for anorexia nervosa. International Journal of Eating Disorders 11 (1992) 235-241
41. Meyer-Lindenberg A.S., Olsen R.K., Kohn P.D., Brown T., Egan M.F., Weinberger D.R., and Berman K.F. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Archives of General Psychiatry 62 (2005) 379-386
42. Mitchell J., Specker S., and de Zwaan M. Comorbidity and medical complications of bulimia nervosa. Journal of Clinical Psychiatry 52 Suppl. (1991) 13-20
43. Pearlstein T., Spurell E., Hohlstein L.A., Gurney V., Read J., Fuchs C., and Keller M.B. A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: A high placebo response. Archives of Women's Mental Health 6 (2003) 147-151
44. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression. Nature Neuroscience 8 (2005) 828-834
45. Pike K.M., Walsh B.T., Vitousek K., Wilson G.T., and Bauer J. Cognitive behavioral therapy in the posthospitalization treatment of anorexia nervosa. American Journal of Psychiatry 160 (2003) 2046-2049
46. Robin A.L., Siegel P.T., Moye A.W., Dennis A.B., and Sikand A. A controlled comparison of family versus individual therapy for adolescents with anorexia nervosa. Journal of the Academy of Child and Adolescent Psychiatry 38 (1999) 1482-1489
47. Romano S.J., Halmi K.A., Sarkar N.P., Koke S.C., and Lee J.S. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. American Journal of Psychiatry 151 (2002) 96-102
48. Russell G.F., Szmulker G.I., Dare C., and Eisler I. An evaluation of family therapy in anorexia nervosa and bulimia nervosa. Archives of General Psychiatry 44 (1987) 1047-1056
49. Striegel-Moore R.H., Leslie D., Petrill S.A., Garvin V., and Rosenheck R.A. One-year use and cost of inpatient and outpatient services among female and male patients with an eating disorder: Evidence from a national database of health insurance claims. International Journal of Eating Disorders 27 (2000) 381-389
50. Strober M., Freeman R., DeAntonio M., Lampert C., and Diamond J. Does adjunctive fluoxetine influence the post-hospital course of restrictor-type anorexia nervosa? A 24-month prospective, longitudinal followup and comparison with historical controls. Psychopharmacology Bulletin 33 (1997) 425-436
51. Strober M., Freeman R., and Morrell W. The long-term course of severe anorexia nervosa in adolescents: Survival analysis of recovery, relapse, and outcome predictors over 10-15 years in a prospective study. International Journal of Eating Disorders 22 (1997) 339
52. Sullivan P.F. Mortality in anorexia nervosa. American Journal of Psychiatry 152 (1995) 1073-1074
53. Telch C.F., Agras W.S., and Lineham M.M. Dialectical behavior therapy for binge eating disorder. Journal of Consulting and Clinical Psychology 69 (2001) 1061-1065
54. Walsh B.T., Fairburn G.C., Mickley D., Sysko R., and Parides M.K. Treatment of bulimia nervosa in a primary care setting. American Journal of Psychiatry 161 (2004) 556-561
55. Walsh B.T., Kaplan A.S., Attia E., Olmsted M., Parides M., Carter J.C., et al. Fluoxetine after weight restoration in anorexia nervosa: A randomized controlled trial. Journal of the American Medical Association 295 (2006) 2605-2612
56. Wilfey D.E., Welch R.R., Stein R.I., Spurrell E.B., Cohen L.R., Saelens B.E., et al. A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Archives of General Psychiatry 59 (2002) 713-721
57. Wilson G.T., and Shafran R. Eating disorders guidelines from NICE. Lancet 365 (2005) 79-81